Would you please appraise the newly launched IPO of Rossario Biotech, whether hold or sell?
Ans: The company has strong fundamentals with strong growth and high return ratios. The long term growth prospects are also promising. However, at this point, considering the run up seen recently, it is trading at stretched valuations. Therefore, if you have it allotted from the IPO we would recommend to book partial profits in the same, or if you have longer term view 2-3 years, one can hold.